Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852968 · ClinicalTrials.gov registry record
Hippocampal Metabolism and Function in Patients With Type 1 Diabetes
A clinical trial of Diabetes Mellitus and Hypoglycemia, sponsored by University of Minnesota.
- Completed
- Registry status
- 57
- Enrollment target
- 1
- Study location
NCT01852968: Completed study of Diabetes Mellitus and Hypoglycemia, sponsored by University of Minnesota.
NCT01852968 is a study of Diabetes Mellitus and Hypoglycemia that has completed, run by University of Minnesota. The registered enrollment target is 57 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01852968, a study of Diabetes Mellitus and Hypoglycemia, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The hippocampus is an area of brain which plays an essential role in learning and memory processing and is thought to be particularly vulnerable to effects of hypoglycemia (low blood glucose). The goal of this project is to examine hippocampal neurochemistry and metabolism and identify how diabetes and recurrent hypoglycemia alter the hippocampus.
Primary Outcome
Hippocampal glucose transport kinetics will be examined using magnetic resonance spectroscopy
Conditions Studied
Study Locations (1)
Minnesota
- Clinical and Translational Science Institute and Center for Magnetic Resonance Research, University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2013-05 |
| Est. Completion | 2017-10-31 |
What the finished NCT01852968 record still lists
NCT01852968 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT01852968 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01852968 about?
NCT01852968 is a clinical study titled "Hippocampal Metabolism and Function in Patients With Type 1 Diabetes". The hippocampus is an area of brain which plays an essential role in learning and memory processing and is thought to be particularly vulnerable to effects of hypoglycemia (low blood glucose). The goal of this project is to examine hippocampal neurochemistry and metabolism and identify how diabetes ...
What is the current status of trial NCT01852968?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2013-05. Estimated completion is 2017-10-31.
What conditions does trial NCT01852968 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Hypoglycemia.
Who is sponsoring clinical trial NCT01852968?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01852968 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01852968's enrollment target sits among peer trials
57 147th of 208 higher than 62 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia